lenalidomide has been researched along with Glomerulonephritis, Membranoproliferative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, N; Kakimoto, T; Kusunoki, Y; Namba-Hamano, T; Takeji, M; Teramoto, K; Wakabayashi, K; Yamamoto, S | 1 |
| Boileau, J; Goetz, J; Gorse, A; Martin, T; Stoll-Keller, F | 1 |
2 other study(ies) available for lenalidomide and Glomerulonephritis, Membranoproliferative
| Article | Year |
|---|---|
A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Dexamethasone; Glomerulonephritis, Membranoproliferative; Humans; Immunoglobulin A; Immunoglobulin lambda-Chains; Immunohistochemistry; Immunologic Factors; Lenalidomide; Male; Microscopy, Electron; Multiple Myeloma; Nephrotic Syndrome; Paraproteinemias; Renal Insufficiency; Treatment Outcome | 2020 |
Parvovirus B19-induced type II mixed cryoglobulinemia.
Topics: Acute Disease; Antibodies, Viral; Antineoplastic Agents; Cryoglobulinemia; Diagnosis, Differential; DNA, Viral; Glomerulonephritis, Membranoproliferative; Humans; Lenalidomide; Male; Middle Aged; Parvoviridae Infections; Parvovirus B19, Human; Thalidomide; Viral Load; Virulence | 2011 |